| Title |
Use of SGLT2 inhibitors in type 2 diabetes: weighing the risks and benefits
|
|---|---|
| Published in |
Diabetologia, August 2018
|
| DOI | 10.1007/s00125-018-4663-6 |
| Pubmed ID | |
| Authors |
Beatrice C. Lupsa, Silvio E. Inzucchi |
X Demographics
The data shown below were collected from the profiles of 120 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 40 | 33% |
| Mexico | 4 | 3% |
| United Kingdom | 4 | 3% |
| United States | 3 | 3% |
| India | 2 | 2% |
| Saudi Arabia | 2 | 2% |
| Brazil | 2 | 2% |
| Chile | 2 | 2% |
| Argentina | 2 | 2% |
| Other | 17 | 14% |
| Unknown | 42 | 35% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 80 | 67% |
| Practitioners (doctors, other healthcare professionals) | 24 | 20% |
| Scientists | 9 | 8% |
| Science communicators (journalists, bloggers, editors) | 7 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 253 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 253 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 30 | 12% |
| Student > Bachelor | 30 | 12% |
| Researcher | 21 | 8% |
| Other | 16 | 6% |
| Student > Doctoral Student | 14 | 6% |
| Other | 51 | 20% |
| Unknown | 91 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 88 | 35% |
| Biochemistry, Genetics and Molecular Biology | 16 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 13 | 5% |
| Agricultural and Biological Sciences | 6 | 2% |
| Chemistry | 5 | 2% |
| Other | 25 | 10% |
| Unknown | 100 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 73. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 December 2021.
All research outputs
#597,485
of 25,732,188 outputs
Outputs from Diabetologia
#293
of 5,376 outputs
Outputs of similar age
#12,630
of 343,313 outputs
Outputs of similar age from Diabetologia
#9
of 69 outputs
Altmetric has tracked 25,732,188 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,376 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.7. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 343,313 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 69 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.